These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Hershey's current stock decline is due to high cocoa prices, but historical trends suggest recovery once prices normalize.

Popular GLP-1 drugs may reduce risks for other conditions such as dementia, psychosis and more But they come with potential risks Side effects include nausea, vomiting, arthritis and more TUESDAY ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Vanessa Kanu Kanu; Executive Vice President and Chief Financial Officer; Aptargroup Inc Ladies and gentlemen, thank you for standing by. Welcome to Aptar 2024 fourth quarter and annual results ...

For a menu of food and drinks for 10 people including fan favorites, consumers will spend $139.1, virtually the same as last year ...

The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...

A RECENT population-based analysis has highlighted potential behavioural side effects associated with Glucagon-like peptide 1 ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have been ...

Popular GLP-1 medications approved for weight loss ... benefit analysis," he said.Though people have shared personal stories of the medications' sometimes surprising side effects, such as pregnancy, ...

The obesity drug ... side effects that can cause people to discontinue treatment. One way drugmakers say they could boost weight loss is by simultaneously targeting multiple metabolic hormones with a ...